Research Article
Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial
Table 1
Baseline characteristics of the randomized participants.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are (SD), median (interquartile range (IQR)), or counts (percentage) unless otherwise noted. †Sequence A, metformin nonmetformin; sequence B, nonmetformin metformin. ‡Tanner stage was presented as median (range). § (mg/dL, to convert TG values from mmol/L to mg/dL, divide by 0.0113). BMI: body mass index; BP: blood pressure; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride; CGM: continuous glucose monitoring; MBG: mean blood glucose; %CV: coefficient of variability of glycemia; MAGE: mean amplitude of glycemic excursions; MODD: means of daily differences; HRV: heart rate variability; SDNN: standard deviation of all RR intervals; SDANN: standard deviation of all the 5-minute RR intervals; RMSSD: square root of the mean of the sum of squares of differences between adjacent RR intervals; PNN50: the percentage of the interval differences of successive RR intervals greater than 50 ms; LF: low frequency; HF: high frequency; LF/HF: low frequency/high frequency. |